JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, T.
Right arrow Articles by Carlstedt-Duke, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, T.
Right arrow Articles by Carlstedt-Duke, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 34, Issue of August 22, 1997 pp. 21090-21095
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

The Rat Glucocorticoid Receptor Mutant K461A Differentiates between Two Different Mechanisms of Transrepression

(Received for publication, March 11, 1997, and in revised form, May 30, 1997)

Thomas Meyer Dagger § , D. Barry Starr and Jan Carlstedt-Duke Dagger

From the Departments of Dagger  Medical Nutrition and § Biosciences, Novum, Karolinska Institutet, Huddinge Hospital, S-141 86 Huddinge, Sweden and  Departments of Cellular and Molecular Pharmacology, and Biochemistry and Biophysics, PIBS Biochemistry and Molecular Biology Program, University of California San Francisco, San Francisco, California 94143-0450

The glucocorticoid receptor (GR) can both activate and repress transcription of target genes by interaction with specific genomic response elements, glucocorticoid response elements (GREs). Activation of transcription is usually the result of the direct interaction between GR and the GRE, whereas GR-mediated transcription repression is either the result of the indirect action of GR, mediated by a response element as a result of protein·protein interaction or by an occlusion mechanism in which GR displaces a general or regulatory transcription factor. A specific mutation of rat GR, K461A, has previously been described to transform the indirect protein·protein interaction-dependent transrepressive effect of GR into an activating function (Starr, D. B., Matsui, W., Thomas, J. R., and Yamamoto, K. R. (1996) Genes Dev. 10, 1271-1283). In HOS D4 and COS7 cells, this mutation was shown to transform the transrepressive effect of wild-type GR, acting on reporter constructs containing the composite GRE from the proliferin gene (plfG) or the negative tethering GRE from the collagenase A promoter (colA), into an activating function. In contrast, the K461A mutation had no effect on the transrepressive effect of GR on the human osteocalcin gene in which repression apparently occurs through the binding of GR to a negative GRE that overlaps the TATA box. The transrepressive function, typically 40% of the basal level in the absence of hormone, required only the isolated DNA-binding domain of wild type or mutant GR and was independent of the nature of transactivation domain. Thus, mutation of rat GR at position 461 differentiates between transrepressive functions of GR dependent on GR·DNA interaction (repression by occlusion) and GR·protein interaction (active repression).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
O. Latchoumanin, V. Mynard, J. Devin-Leclerc, M.-A. Dugue, X. Bertagna, and M. G. Catelli
Reversal of Glucocorticoids-Dependent Proopiomelanocortin Gene Inhibition by Leukemia Inhibitory Factor
Endocrinology, January 1, 2007; 148(1): 422 - 432.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Koyanagi, H. Suyama, Y. Kuramoto, N. Matsunaga, H. Takane, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo
Glucocorticoid Regulation of 24-Hour Oscillation in Interferon Receptor Gene Expression in Mouse Liver
Endocrinology, November 1, 2006; 147(11): 5034 - 5040.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Martens, S. Bilodeau, M. Maira, Y. Gauthier, and J. Drouin
Protein-Protein Interactions and Transcriptional Antagonism between the Subfamily of NGFI-B/Nur77 Orphan Nuclear Receptors and Glucocorticoid Receptor
Mol. Endocrinol., April 1, 2005; 19(4): 885 - 897.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Tse, B. A. Marroquin, D. R. Dorscheid, and S. R. White
{beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L393 - L404.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Doppler, M. Windegger, C. Soratroi, J. Tomasi, J. Lechner, S. Rusconi, A. C. B. Cato, T. Almlöf, J. Liden, S. Okret, et al.
Expression Level-Dependent Contribution of Glucocorticoid Receptor Domains for Functional Interaction with STAT5
Mol. Cell. Biol., May 1, 2001; 21(9): 3266 - 3279.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
I. P. Torra, V. Tsibulsky, F. Delaunay, R. Saladin, V. Laudet, J.-C. Fruchart, V. Kosykh, and B. Staels
Circadian and Glucocorticoid Regulation of Rev-erb{alpha} Expression in Liver
Endocrinology, October 1, 2000; 141(10): 3799 - 3806.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Meyer, M. Kneissel, J. Mariani, and B. Fournier
In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism
PNAS, July 12, 2000; (2000) 150246097.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Verrey
Early aldosterone action: toward filling the gap between transcription and transport
Am J Physiol Renal Physiol, September 1, 1999; 277(3): F319 - F327.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Aarnisalo, H. Santti, H. Poukka, J. J. Palvimo, and O. A. Jänne
Transcription Activating and Repressing Functions of the Androgen Receptor Are Differentially Influenced by Mutations in the Deoxyribonucleic Acid-Binding Domain
Endocrinology, July 1, 1999; 140(7): 3097 - 3105.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Subramaniam, W. Cairns, and S. Okret
Glucocorticoids Repress Transcription from a Negative Glucocorticoid Response Element Recognized by Two Homeodomain-containing Proteins, Pbx and Oct-1
J. Biol. Chem., September 4, 1998; 273(36): 23567 - 23574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. J. Shah, J. A. Iniguez-Lluhi, A. Romanelli, S. R. Kimball, and L. S. Jefferson
The Activated Glucocorticoid Receptor Modulates Presumptive Autoregulation of Ribosomal Protein S6 Protein Kinase, p70 S6K
J. Biol. Chem., January 18, 2002; 277(4): 2525 - 2533.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Meyer, M. Kneissel, J. Mariani, and B. Fournier
In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism
PNAS, August 1, 2000; 97(16): 9197 - 9202.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.